🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the efficacy and safety of first-line tr...
Status
Completed
Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Start Date
2018-05-24
Trial ID
NCT03462251
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
This study is a prospective, open-label, multicenter, randomized controlled...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT07005557
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
Women with recurrent or metastatic breast cancer who are hormone receptor p...
Status
Unknown
Location
Clinical oncology department, Faculty of medicine, Ain Shams University
Start Date
2018-08-30
Trial ID
NCT04012918
Treatments Being Tested
This trial studies the effects on quality of life and on time to second pro...
Status
Terminated
Location
NKI-AVL
Start Date
2008-04
Trial ID
NCT00684216
Treatments Being Tested
The primary objective of this study is to compare progression-free survival...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2013-09-16
Trial ID
NCT01950182
Treatments Being Tested
The present study is to determine the adverse effects and clinical efficacy...
Status
Unknown
Location
FUSCC
Start Date
2010-10
Trial ID
NCT01924078
Treatments Being Tested
To compare the combination of Ribociclib plus goserelin acetate with hormon...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-25
Trial ID
NCT03839823